119th Congress

H.R. 4101

Cancer Drug Parity Act of 2025

Introduced
In committee
Passed House
Passed Senate
To President
Became law

Sponsor: Glenn Grothman(R-WI)
Introduced: Jun 24, 2025
Policy area: Health
Committees: House Committee on Education and Workforce
Official text: Introduced in House · Congress.gov page

Cosponsors (31)

Original cosponsors (10)

Added later (21)

Kathy Castor (D-FL) · Jun 25, 2025
Timothy M. Kennedy (D-NY) · Jun 25, 2025
Jamie Raskin (D-MD) · Sep 9, 2025
Becca Balint (D-VT) · Sep 15, 2025
Eleanor Holmes Norton (D-DC) · Sep 15, 2025
Robert P. Bresnahan, Jr. (R-PA) · Sep 30, 2025
Eugene Simon Vindman (D-VA) · Oct 3, 2025
Deborah K. Ross (D-NC) · Oct 8, 2025
John Garamendi (D-CA) · Oct 17, 2025
Chrissy Houlahan (D-PA) · Oct 21, 2025
Jonathan L. Jackson (D-IL) · Oct 24, 2025
Andrea Salinas (D-OR) · Nov 7, 2025
Herbert C. Conaway, Jr. (D-NJ) · Nov 7, 2025
Janelle S. Bynum (D-OR) · Nov 7, 2025
Chris Pappas (D-NH) · Dec 18, 2025
Joe Neguse (D-CO) · Dec 18, 2025
Derek Schmidt (R-KS) · Mar 16, 2026
Ed Case (D-HI) · Jul 27, 2026
William R. Keating (D-MA) · Aug 20, 2026
Chellie Pingree (D-ME) · Oct 9, 2026
Mark Pocan (D-WI) · Oct 9, 2026

Summary

No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.

Official title: To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider.

Latest action(Jun 24, 2025): Referred to the House Committee on Education and Workforce.

Read the official text

Roll-call votes

No recorded votes on this bill.

Actions

Jun 24, 2025 · House
Referred to the House Committee on Education and Workforce.
Jun 24, 2025
Introduced in House